MAY ANN COLEMAN: Open Payments
NPI 1033661632 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,667 in 200 payments from 22 companies in 2025. Trend: 2023 $577 · 2024 $2,069 · 2025 $3,667
Food & beverage: $3,568Education: $99
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 21 | $494 |
| Alkermes, Inc. | 34 | $472 |
| ABBVIE INC. | 23 | $400 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $380 |
| Otsuka America Pharmaceutical, Inc. | 21 | $276 |
| Lundbeck LLC | 14 | $276 |
| Teva Pharmaceuticals USA, Inc. | 15 | $256 |
| Axsome Therapeutics, Inc. | 11 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $139 |
| Tris Pharma Inc | 5 | $111 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, ARISTADA, REXULTI, ABILIFY MAINTENA, Auvelity, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
